Logo
x

Search

Subscribe Now

G1 Therapeutics

G1 Therapeutics Partners with Pepper Bio for Lerociclib

G1 Therapeutics Partners with Pepper Bio for Lerociclib

  • May 1, 2024
G1 Therapeutics Presents Preliminary Results from P-II Trial of Trilaciclib for Triple-Negative Breast Cancer at ESMO 2023

G1 Therapeutics Presents Preliminary Results from P-II Trial of Trilaciclib for Triple-Negative Breast Cancer at ESMO 2023

  • May 12, 2023
G1 Therapeutics Reports P-III Trial (PRESERVE 1) Results of Trilaciclib for Metastatic Colorectal Cancer

G1 Therapeutics Reports P-III Trial (PRESERVE 1) Results of Trilaciclib for Metastatic Colorectal Cancer

  • February 14, 2023
Insights+: The US FDA New Drug Approvals in February 2021

Insights+: The US FDA New Drug Approvals in February 2021

  • March 18, 2021
PharmaShots Weekly Snapshots (Mar 01 - 05, 2021)

PharmaShots Weekly Snapshots (Mar 01 - 05, 2021)

  • March 5, 2021
PharmaShots Weekly Snapshot (Aug 17 -21 2020)

PharmaShots Weekly Snapshot (Aug 17 -21 2020)

  • August 21, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.